The Efficacy and Safety of Prostatectomy for Castration-Naive Oligometastatic Prostate Cancer
Status:
Recruiting
Trial end date:
2025-05-01
Target enrollment:
Participant gender:
Summary
This randomized, controlled, multi-center clinical trial aims to evaluate the efficacy and
safety of prostatectomy for castration-Naive oligometastatic prostate cancer
Phase:
Phase 2
Details
Lead Sponsor:
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Collaborators:
Subei people's Hospital The Affiliated Hospital of Nantong University The Affiliated Hospital of Xuzhou Medical University The First Affiliated Hospital of Soochow University The First People's Hospital of Changzhou Wuxi People's Hospital